Lupus & Connective Tissue Diseases
News from the FDA/CDC
FDA approves rituximab to treat children with rare vasculitis
From the Journals
Zostavax proves safe, effective in patients with nonactive SLE
The live-attenuated herpes zoster vaccine appears safe and effective in individuals with nonactive systemic lupus erythematosus.
Feature
Prior authorizations for infusibles cause delays, toxicities
A new study reveals the prior authorization difficulties that patients must go through to receive infusible biologics, providing evidence to...
From the Journals
Study aims to define symptoms of Sjögren’s syndrome secondary to SLE
The study is believed to be the first to investigate whether systemic inflammation, as measured by cytokine levels, differs according to the...
Feature
ACR looks for continued growth in awareness of rheumatic diseases with latest annual campaign
Efforts to raise awareness about rheumatic diseases range from a celebrity public awareness campaign to advocating for legislation on Capitol Hill...
From the Journals
Antimalarial exposure above recommended doses in lupus contributes most retinopathy risk
Chloroquine exposure was three times more common in retinopathy patients.
News
FDA approves nintedanib for scleroderma interstitial lung disease
Interstitial lung disease affects half of scleroderma patients in the United States, and until now there was no treatment.
From the Journals
Cannabidiol may interact with rheumatologic drugs
CBD is known to inhibit the cytochrome P450 enzymes that metabolize corticosteroids and other medications.
Conference Coverage
In vasculitis, the skin tells the story
MILAN – Confirmatory lab testing – and assessing for renal involvement – are still paramount, however.
Conference Coverage
EULAR updates vaccination recommendations for autoimmune inflammatory rheumatic disease patients
EULAR’s updated guidance on vaccinations for patients with AIIRD starts with an annual status assessment.
From the Journals
Peripheral nervous system events have lasting impact on SLE patients
Findings from one of the largest-ever cohort studies on PNS manifestations in SLE patients may “provide a benchmark for the assessment of future...